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A rare case of Kikuchi-Fujimoto disease (case report) 
 
 
Abstract 
Background: Kikuchi disease is a rare, benign, self-limited disease characterized 
primarily by fever and cervical lymphadenopathy. Diagnosis is based on excisional 
biopsy and pathologic study. We report a case of an atypical axillary lymph node 
enlargement. 
Case report: This patient was a 12-year-old boy with clinical characteristics 
including axillary lymph adenopathy, fever and fatigue. He became asymptomatic 
after excisional biopsy. Histologic study reported necrotizing lymphadenitis 
without neutrophils (Kikuchi disease). 
Conclusions: These findings are important for diagnosis, because of the disease 
rarity, clinical features (such as lymphadenopathy, prolonged fever) and 
unidentified etiology.  
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Introduction 
Kikuchi disease also known as histiocytic necrotizing lymphadenitis or kikuchi 
Fujimoto disease (KFD) is a benign and self-limited disease, which has been first 
reported in Japan in 1972 [1,2, 3]. It is rare and has a worldwide distribution with a 
higher prevalence among Japanese and other Asiatic individuals [4]. Pileri et al. 
reported 23 cases from Germany, Spain, Italy, Iran, and South Korea [5]. The initial 
presentation includes cervical lymphadenopathy, fever, skin rash, headache, 
fatigue, leukopenia [6], rarely night sweat, weight loss, aseptic meningitis, 
myocarditis, pneumonitis, hepatosplenomegaly and acute kidney injury [7, 8, 9], and 
more often, it occurs in children 8-16 yr of age [3]. Its etiology has remained 
unknown [3], but infectious agents including Epstein – Barr virus (EBV), 
cytomegalovirus, human herpes virus 6 and 8, parvovirus B19, Toxoplasma, 
Yersinia have been reported to have a causative role, but no specific agents have 
been identified [10, 11]. KFD is a self-limited benign condition that spontaneously 
appears to resolve within weeks to 6 months; however, 3-4% of patients will 
experience recurrent episode of KFD. In spite of its rarity in the pediatric 
population, KFD clinically should be differentiated from other infectious diseases 
(such as cat scratch disease, bacterial lymphadenitis and tuberculosis), lymphoma 
and systemic lupus erythematosus (SLE). The results of a wide range of laboratory 
tests are usually normal in patient with KFD. Anemia, mild leucopenia and slight 
elevation of ESR are the most common abnormal laboratory findings [12]. Diagnosis 
of KFD is based on excisional biopsy and histological examination [5-7]. The 
pathological features of KFD include lymph node necrosis with karyorrhexis 
surrounded by histocytes without granuloma neutrophil or plasma cell infiltration [5]. 
Immunohistologic study of lymph node may reveal the large cells, in KFD are 
CD8-positive immunoblasts and CD68-positive histiocytes [7]. Treatment is 
suggested unnecessary and not recommended unless there is coincidence with SLE [6].  
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In this study, we report a case of an atypical 
axillary lymph node enlargement in an Iranian child. 
 
 
Case Report 
A 12-year-old boy was admitted to our center 
because of a 5-day history of fever, fatigue and left 
axillary lymph node enlargement 2 weeks before 
admission. The patient had no complaints of sore 
throat, night sweat, and headache.  
Clinical history did not reveal any travel, exposure 
to animals or insect bites. On admission, the patient 
was in good general condition even with an axillary 
temperature of 40oC. On examination, there was only 
unilateral, non- fluctuant swelling, immobile and 
tender 1*1.5 cm lymphadenopathy and no skin rash on 
the trunk and limbs. In addition, there was no 
hepatosplenomegaly or palpable mass in abdominal 
exam. 
Other physical examinations were normal. 
Complete blood cell demonstrated a white blood 
cell count of 3.3*109/L, with 43% neutrophil, 54%, 
lymphocyte, 2% monocyte, 1% eosinophil and platelet 
count of 64*109/L and hemoglobin was 11.4 mg/dl. 
Urine analysis, liver and renal function tests, ESR and 
CRP were normal and blood culture was negative for 
bacterial and fungal infection. The results for EBV 
capsid antigen, PPD test, Wright, Coombs Wright and 
Widal tests, ANA, anti-ds-DNA and chest x-ray and 
abdominopelvic sonography were normal. 
Bone marrow aspiration studies were normal 
without any abnormal cells or excess blasts. 
Intravenous antibiotics were initiated immediately. 
Fever continued 13 days after hospitalization and using 
intravenous antibiotics; therefore, the excisional biopsy 
was done. Fever stopped 24 hours after excisional 
biopsy. 
Histologic study reported necrotizing lymphadenitis 
without neutrophils (Kikuchi disease). 
Immunohistologic study was reported that CD3 
polyclonal rabbit anti–human was strongly positive, 
CD20 (L26) was weakly positive, CD68 clone and PG-
M1 in many cells were positive, CD30- Ki-1 antigen 
close ber H-Z was positive in non-atypical 
predominantly cell, but CD 10 clone and 56 C6 were 
negative. 
 
 
Discussion: 
This study reported the clinical presentation of 
KFD by axillary lymphadenopathy, which was not 
common. Although KFD has shown a female 
predominance, most pediatric studies have reported a 
male predominance [13-18].Patients may present with 
fever, chills, weight loss, arthralgia, splenomegaly, 
abdominal pain, fatigue and skin rash [7, 12, 19-23]. Our 
case was a 12-year-old boy in good condition with 
fever, fatigue and unilateral axillary lymph node about 
2 weeks before admission.  
However, the most common presenting symptom, 
unilateral cervical lymphadenopathy, has been  
reported [12, 22-27]. In only a few cases, the lymphadenopathy 
involved the peritoneal and supraclavicular nodes [12, 20, 21]. 
The affected node in our patient was unilateral non-
fluctuant, swelling immobile and tender in axillary. 
The size of lymph nodes was usually less than 3 cm 
in previous reports [11, 12, 24-26]; however, they may reach 
5-6 cm in diameter [7]. The size of lymph node in our 
patient was 1*1.5 cm. 
Approximately 40% of patients experienced 
leukopenia (<4000/µl) and 15% presented with 
thrombocytopenia (<150000/µl) based on Kim's report [26]. 
Our patient had leukopenia (3300/µl) and 
thrombocytopenia (64000/µl) which were not common 
in the previous study [24, 26]. 
Unlike the study of Dumas et al., the reported 
patient in the current study was male and his disease 
was not severe [27]. 
Diagnosis of KFD was based on excisional biopsy 
and histological study in all cases [5-7, 12, 19, 22, 24-27]. 
Immunohistochemistry staining study of lymph 
node for KFD indicated that CD4, CD8, CD3 were 
positive but CD11-b was negative [28]. In another study, 
CD20, CD 10, CD3, CD43, and CD30 were positive [6]. 
Immunohistochemistry staining study from excisional 
lymph node biopsy in our case was positive in CD3, 
CD20, CD 68 and negative for CD10. Our patient 
became afebrile 24 hours after excisional biopsy and 
did not have other problems. 
In conclusion, persistent lymph node enlargement with 
a prolonged fever requires a careful differential 
diagnosis which should include the possibility of KFD. 
Through careful diagnosis patients with KFD may avoid 
unnecessary treatment with aggressive chemotherapy. 
More research and attention should be directed towards 
the etiology of the disease.   
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